Rogers Toby, Waksman Ron, Harrison J Kevin, Deeb G Michael, Zhang Angie Q, Hermiller James B, Popma Jeffrey J, Reardon Michael J
Section of Interventional Cardiology, MedStar Washington Hospital Center, Washington, District of Columbia; Cardiovascular Branch, Division of Intramural Research, National Heart Lung and Blood Institute, Bethesda, Maryland.
Section of Interventional Cardiology, MedStar Washington Hospital Center, Washington, District of Columbia.
Am J Cardiol. 2018 Jun 1;121(11):1358-1364. doi: 10.1016/j.amjcard.2018.02.008. Epub 2018 Mar 1.
The impact of predilatation (Pre-Dil) on prosthesis hemodynamics and clinical outcomes of subjects who underwent transcatheter aortic valve implantation (TAVI) with a self-expanding prosthesis remains unclear. Two thousand seven hundred twenty-one subjects from the extreme- and high-risk CoreValve Continued Access Study (CAS) were included in the analysis. Subjects who underwent Pre-Dil before TAVI were compared with subjects who underwent TAVI without Pre-Dil. Clinical outcomes included death, stroke, myocardial infarction, acute kidney injury, and new permanent pacemaker implantation. Serial echocardiograms were analyzed to evaluate prosthesis hemodynamics, specifically paravalvular regurgitation, effective orifice area, and mean gradient. Two thousand one hundred eighteen and 603 subjects underwent TAVI with and without Pre-Dil, respectively. Subjects in the Pre-Dil cohort were more commonly male, while subjects in the no Pre-Dil cohort had higher rates of previous stroke and lower mean aortic valve gradients. Outcomes at 30 days were comparable between Pre-Dil and no Pre-Dil subjects, with no significant difference in mortality (5.5% vs 4.3%, p = 0.27), major stroke (2.6% vs 2.2%, p = 0.54), major vascular complications (6.9% vs 8.0%, p = 0.37), major bleeding (24.4% vs 26.1%, p = 0.40), and permanent pacemaker implantation (21.3% vs 23.4%, p = 0.36). There were no significant differences in the same outcomes at 12 months. Effective orifice area and mean gradient were comparable between Pre-Dil and no-Pre-Dil subjects at discharge, at 30 days, and at 12 months. In conclusion, when performing TAVI with the self-expanding CoreValve device, performing direct implantation without Pre-Dil maintains an acceptable safety profile and still achieves desired and consistent prosthesis hemodynamics.
预扩张对接受经导管主动脉瓣植入术(TAVI)且使用自膨式人工瓣膜的患者的人工瓣膜血流动力学及临床结局的影响仍不明确。分析纳入了来自高危和极高危CoreValve持续接入研究(CAS)的2721名患者。将TAVI术前接受预扩张的患者与未接受预扩张的患者进行比较。临床结局包括死亡、卒中、心肌梗死、急性肾损伤及新的永久性起搏器植入。通过连续超声心动图分析评估人工瓣膜血流动力学,特别是瓣周反流、有效瓣口面积及平均跨瓣压差。分别有2118名和603名患者接受了有预扩张和无预扩张的TAVI。预扩张组患者男性更为常见,而无预扩张组患者既往卒中发生率更高,平均主动脉瓣压差更低。预扩张组和无预扩张组患者30天的结局相当,死亡率(5.5%对4.3%,p = 0.27)、严重卒中(2.6%对2.2%,p = 0.54)、主要血管并发症(6.9%对8.0%,p = 0.37)、严重出血(24.4%对26.1%,p = 0.40)及永久性起搏器植入(21.3%对23.4%,p = 0.36)均无显著差异。12个月时这些结局也无显著差异。出院时、30天时及12个月时,预扩张组和无预扩张组患者的有效瓣口面积及平均跨瓣压差相当。总之,使用自膨式CoreValve装置进行TAVI时,不进行预扩张直接植入可维持可接受的安全性,且仍能实现理想且一致的人工瓣膜血流动力学。